Drug Trial Radar · NCT07078695
A Trial of SHR-1139 in Healthy Volunteers
Last checked: Nov 19, 2026Latest source record: Nov 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
24
Planned (sponsor's estimate)
Start
Aug 19, 2025
Primary completion
Nov 9, 2026
Study completion Jan 30, 2027
Sponsor
- Lead sponsor
- Atridia Pty Ltd.Industry
- Sponsor type
- Industry
- First posted
- Jul 22, 2025
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 55 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of this study is to assess safety, PK and immunogenicity profile of a single dose of SHR-1139 in healthy volunteers
Conditions
- Psoriasis
Interventions
SHR-1139 InjectionDrug
Single dose of SHR-1139 given subcutaneously (dose level 1 )
SHR-1139 InjectionDrug
Single dose of SHR-1139 given subcutaneously (dose level 2 )
SHR-1139 InjectionDrug
Single dose of SHR-1139 given intravenously (dose level 3)
Primary outcomes
What the sponsor says the trial is designed to measure.
- PK profile of SHR-1139 after a single administrationTime frame: Start of Treatment to end of study (Day 253)
- PK profile of SHR-1139 after a single administrationTime frame: From time 0 to infinity after SHR-1139 administration (Day 253)
- PK profile of SHR-1139 after a single administration:Time frame: Start of Treatment to end of study (Day 253)
- PK profile of SHR-1139 after a single administrationTime frame: Start of Treatment to end of study (Day 253)
- Immunogenicity profile of SHR-1139 after a single dose administrationTime frame: Day 253
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Linear
Perth, Western Australia, Australia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.